Clinical trial
Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption…
NCT00393978 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00393978 |
|---|---|
| Title | Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania |
| Official title | Quetiapine Plus Topiramate or Placebo for Bipolar Mania & Cannabis Use in Adolescents |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Cannabis-Related Disorder |
| Intervention type | Drug |
| Interventions | Quetiapine and placebo, Quetiapine and Topiramate |
| Enrollment | 75 |
| Start date | Nov 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Mar 1, 2014 |
| First posted | Oct 31, 2006 |
| Last update posted | Sep 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: